Skip to main content
Equibles
TDOC logo

TDOC · Teladoc Health, Inc. · Metrics

Track TDOC — free

Use TDOC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TDOC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.45 +0.21 (+3.37%) At close · Oct 27 Earnings today Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Customer concentration — key customers 31% of revenue

Key customers — 31% of revenue (the three months ended March 31, 2026)

“Revenue from the five largest Clients accounted for 31% of total Integrated Care segment revenue for each of the three months ended March 31, 2026 and 2025.”
View the 10-Q filed Apr 30, 2026
Market Cap
$1.16B
Shares
181.68M
Volume · Oct 27 3.98M Avg daily vol (3M) 4.19M

TDOC metrics

87 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.45
Market cap
$1.16B

Price action

20 metrics
Price change (1W)
+3.9%
Price change (30D)
+9.5%
Price change (3M)
-31.1%
Price change (6M)
+7.5%
Price change (YTD)
-7.9%
Price change (1Y)
-28.4%
Trailing year
Price change (5Y)
-95.3%
52-week high
$9.72
52-week low
$4.47
Change from 52-week high
-33.6%
Change from 52-week low
+44.3%
Annualized volatility
60.1%
Annualized volatility (3M)
71.5%
Beta
1.1
RSI (14D)
59.4
Price vs SMA 50
+5.0%
Price vs SMA 200
-0.1%
Avg volume (3M)
4.19M
Relative volume
1.0
Average dollar volume
$27.13M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
181.68M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.5×
reciprocal yield 214.8%
P / book
0.9
reciprocal yield 113.0%
FCF yield
21.9%
TTM · current market cap
Buyback yield
—
P / FCF
4.6
reciprocal yield 21.9%
P / operating cash flow
4.4
reciprocal yield 22.5%
Earnings yield
-15.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-28
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
-7.5%
Trailing 12 months
Net margin
-7.1%
Gross profit (TTM)
$1.78B
Operating profit (TTM)
−$186.82M
Net income (TTM)
−$177.40M
Trailing 12 months
Diluted EPS (TTM)
$-0.99
FCF margin
10.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$13.93
Gross profit per diluted share (TTM)
$10.91
Operating profit per diluted share (TTM)
$-1.05
EBITDA per diluted share (TTM)
$-22.90
Net income per diluted share (TTM)
$-0.99
Operating cash flow per diluted share (TTM)
$1.46
Free cash flow per diluted share (TTM)
$1.42
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$1.51
Stock compensation per diluted share (TTM)
$0.32
Book value per share
$7.77

Growth

11 metrics
Revenue growth YoY
-4.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.49B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
+1.7%
Revenue CAGR (5Y)
+18.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+18.2%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-13.5%
Return on assets
-6.4%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
−$3.71B
Free cash flow (TTM)
$253.70M
Quick ratio
0.8
Interest coverage
-9.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$774.35M
Total assets
$2.76B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$261.18M
Capital expenditures (TTM)
$7.49M
R&D (TTM)
$269.91M
SG&A (TTM)
—
Stock compensation (TTM)
$56.82M
R&D / revenue
10.8%
Stock compensation / revenue
2.3%

Ownership (13F)

9 metrics
13F filers
354
13F filer change QoQ
+22
Institutional ownership
89.4%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
26.5%
Private-fund adviser ownership
23.7%
Active holders' share change QoQ
+5.8%
Holder tenure
13.3
Price vs estimated holder cost
-15.9%

Ownership (registered funds)

1 metrics
Index-fund ownership
18.6%

Short interest

3 metrics
Short interest
17.7%
Latest settlement · 8.2 days to cover
Days to cover
8.2d
Short-squeeze score
85 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$460,877
Insider-sentiment score
25 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1477449 CUSIP 87918A105 13F (30d) 70 filings 67 filers Visit website Investor relations